“Space experiments are so complex that they force you to do better science on the ground,” continued Jamieson. “Space research has accelerated technological advancements on Earth, making ground-based research easier and more relevant to human health. What we have learned about cancer from our studies in space is absolutely remarkable.”
Link to full study.
Additional co-authors on the study include: Jessica Pham, Jane Isquith, Larisa Balaian, Shuvro P. Nandi, Claire Engstrom, Karla Mack, Inge van der Werf, Patrick Chang, Jana Stoudemire, Luisa Ladel, Emma Klacking, Antonio Ruiz, Daisy Chilin-Fuentes, Jenna Sneifer, Alysson R. Muotri, Thomas Whisenant and Ludmil B. Alexandrov from UC San Diego. David Mays, Paul Gamble, Shelby Giza, Jiya Janowitz, Trevor Nienaber and Twyman Clements from Space Tango. Tejaswini Mishra and Michael P. Snyder from Stanford University School of Medicine. Anna A. Khachatrian from Scripps Health. Elsa Molina and Sheldon R. Morris from The Salk Institute for Biological Studies.
The study was funded, in part, by NASA (NRA NNJ13ZBG001N) to UC San Diego Sanford ISSCOR Center; NCI (R01CA205944); NIH/NIDDK (R01DK114468-01); NIH NCI CCSG p30CA023100; NIH NCI CCSG: P30 CA01495; NIH NIA San Diego Nathan Shock Center (P30 AG068635); The Chapman Foundation and the Helmsley Charitable Trust; LLS Blood Cancer Discoveries; Sanford Stem Cell Institute; Koman Family Foundation; JM Foundation and Moores Family Foundation.
Disclosures: Jamieson is a co-founder of Impact Biomedicines and Aspera Biomedicines and has received royalties from Forty Seven Inc. Morris is a co-founder of Aspera Biomedicines. Mack is an employee of Aspera Biomedicines. Snyder is a co-founder of Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, Protos, Protometrix (now part of Thermo-Fisher) and Affomix (now part of Illumina). Muotri is a co-founder and has equity interest in TISMOO. Balaian is a co-founder of IO9. Ladel, Pham, Balaian, Ruiz, Klacking, Whisenant and Jamieson are named on patents related to this work. Other authors declare no competing interests.